Johann-Nepomuk Ernst Josef Hoffer von Ankershoffen
โ˜• ๐Œ๐Ž๐‘๐๐ˆ๐๐† ๐—จ๐—ฃ๐——๐—”๐—ง๐—˜ - ๐—–๐—ผ๐—บ๐—ฒ๐—ฏ๐—ฎ๐—ฐ๐—ธ?!๐Ÿ“ˆ ๐Ÿ‡ฉ๐Ÿ‡ช ๐“๐จ๐ฉ 5๏ธโƒฃ ๐Ÿ˜Ž 9๏ธโƒฃ9๏ธโƒฃ4๏ธโƒฃ ๐—ฐ๐—ผ๐—ฝ๐—ถ๐—ฒ๐—ฟ๐˜€ ๐Ÿ“Š ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ: +54.77% ๐Ÿ“Š ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ: +79.49% ๐Ÿ“Š ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ: +15.93% ๐Ÿ“Š ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: -13.37% ๐ŸŒ… ๐†๐จ๐จ๐ ๐ฆ๐จ๐ซ๐ง๐ข๐ง๐  ๐ž๐ฏ๐ž๐ซ๐ฒ๐จ๐ง๐ž! The start of August has been very encouraging โ€“ both for the markets and for our portfolio. On a weekly basis, we are now up ๐จ๐ฏ๐ž๐ซ ๐Ÿ–%. This has allowed us to close part of the gap to the major indices, although we still have some ground to make up after the past few months. ๐Ÿš€ ๐€๐ˆ ๐ˆ๐ง๐Ÿ๐ซ๐š๐ฌ๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐ž ๐‚๐จ๐ง๐ญ๐ข๐ง๐ฎ๐ž๐ฌ ๐ญ๐จ ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ The main reason for this strong start to the week has been the impressive rebound in the technology and AI sector. Within our core portfolio, we continue to focus on ๐€๐ˆ ๐ข๐ง๐Ÿ๐ซ๐š๐ฌ๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐ž. This is where I currently see the strongest long-term visibility. Many companies already have order books filled for years ahead and are now facing the challenge of keeping up with demand rather than finding new customers. A great example is $AEHR (Aehr Test System) , whose stock gained around ๐Ÿ๐ŸŽ% yesterday alone. ๐Ÿงฌ ๐“๐ก๐ž ๐’๐š๐ญ๐ž๐ฅ๐ฅ๐ข๐ญ๐ž ๐’๐ž๐œ๐ญ๐จ๐ซ ๐ˆ๐ฌ ๐€๐ฅ๐ฌ๐จ ๐‚๐จ๐ง๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐ง๐  It wasn't just AI stocks performing well this week. We continue to maintain a strong exposure to the healthcare sector within our satellite sector. Our largest position, $RVMD (REVOLUTION Medicines Inc) , is currently up around ๐Ÿ๐ŸŽ% and has been one of the strongest contributors to our recent performance. $BAYN.DE (Bayer AG) also delivered solid quarterly results. The stock was up around ๐Ÿ’% at one point yesterday and looks set to open higher again today. ๐Ÿ“… ๐Œ๐จ๐ซ๐ž ๐„๐š๐ซ๐ง๐ข๐ง๐ ๐ฌ ๐“๐จ๐๐š๐ฒ The earnings season continues. Today, all eyes will be on $LLY (Eli Lilly & Co) and $RVMD , as both companies report their quarterly results. They are important positions in our portfolio and could create further momentum. ๐Ÿ™ ๐€ ๐…๐ข๐ง๐š๐ฅ ๐“๐ก๐จ๐ฎ๐ ๐ก๐ญ We are moving in the right direction again, and now it's about building on this positive momentum step by step. A big thank you to everyone who continues to trust me and stays invested alongside me. And as I often say: ๐“๐ก๐ž ๐›๐ž๐ฌ๐ญ ๐ž๐ง๐ญ๐ซ๐ฒ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ซ๐š๐ซ๐ž๐ฅ๐ฒ ๐š๐ฉ๐ฉ๐ž๐š๐ซ ๐ฐ๐ก๐ž๐ง ๐š ๐ฉ๐จ๐ซ๐ญ๐Ÿ๐จ๐ฅ๐ข๐จ ๐จ๐ซ ๐š ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ซ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐จ๐ซ ๐ข๐ฌ ๐š๐ญ ๐š๐ง ๐š๐ฅ๐ฅ-๐ญ๐ข๐ฆ๐ž ๐ก๐ข๐ ๐ก. More often, they appear after challenging periods. I wish you all a successful trading day! ๐Ÿ“ˆโ˜€๏ธ all the best JvA
Not investment advice. The author may have financial interests in the mentioned instruments.
null
.